How would you treat high risk prostate adenocarcinoma who relapsed after RT and ADT with a very low PSA, widespread mets to bone and soft tissue who is progressing on ADT, docetaxel and carboplatin?  

No targetable mutations detected



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Rush University Medical Center
I generally agree with the concern for neuro endoc...
Sign in or Register to read more